Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Finasteride shows promise for female hair loss, but more research needed.

Postmenopausal women with hair loss should get proper tests and consider treatments like minoxidil.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Many Iraqi women with hirsutism also have hypothyroidism and acne.

Female pattern hair loss may indicate metabolic issues and increased cardiovascular risk.

Hyperandrogenism causes significant physical and emotional challenges, needing better understanding and support.

Hirsutism is relatively common among young Greek women.

The document's conclusion cannot be provided as the content is not in a language that I can process. Please provide content in English for a summary.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Changes in scalp bacteria are linked to female hair loss, suggesting new treatment options.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

CAM practitioners in the eThekwini area are exploring ways to manage and diagnose Polycystic Ovarian Syndrome.

Early assessment and treatment by healthcare professionals can help manage hair loss in women.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Homeopathic treatment improved thyroid function and well-being in a woman with hypothyroidism.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Women with PCOS need more support to cope with isolation, helplessness, and grief, and to build resilience.

Women with hair loss often have deficiencies in iron, vitamins, minerals, and lower thyroid function, suggesting the need for nutritional and hormonal treatment.

Australian women with female pattern hair loss have a poorer quality of life, and starting treatment doesn't immediately improve it.

The LGBTQ+ STEM @UCL Network helps increase visibility and support for LGBTQ+ individuals in STEM at University College London.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.